Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

Stay Away from Floundering Nikola Shares

By Thomas Niel, InvestorPlace Contributor
If Nikola stock performs like this in boom times, how are things going to be if the EV bubble starts to burst? Avoid buying shares for now.

Avoiding Genius Brands International Is a No-Brainer

By Lou Carlozo, InvestorPlace Contributor
Though Genius Brands International is devoted to kids entertainment, investing in GNUS stock is anything but child's play.

The Key Reasons Investors Should Avoid Inovio Pharmaceuticals Stock

By Ian Cooper, InvestorPlace Contributor
The first time I highlighted opportunity in Inovio Pharmaceuticals (NASDAQ:INO), it traded at just $4.86 a share. That was in late January. By July, the…

With A Lot of Sizzle, and Little Steak, Avoid Workhorse Stock

By Thomas Niel, InvestorPlace Contributor
Emphasis on the phrase "on paper." The USPS bid (which may not even pay off if won) is already factored into the share price. So is the Lordstown catalyst, and whatever else the came has up its sleeve. With this in mind, if you own WKHS stock, it's time to sell into strength. If you don't own it already, avoid shares completely.

At This Point, Nvidia Stock Is Just Too Expensive to Chase

By Luke Lango, InvestorPlace Senior Investment Analyst
Thanks to a super stretched valuation, the risk-reward profile on NVDA stock now skews significantly towards the downside.

Naked Brand Group Isn’t a Buy, But a Barometer

By Josh Enomoto, InvestorPlace Contributor
With falling sales growth, you should avoid NAKD stock for now. Still, Naked shares offer an eye-opening insight about the consumer.

Wait For Confirmation Before Signing Off on Docusign Stock

By Chris Markoch, InvestorPlace Contributor
Docusign stock is unquestionably a pandemic winner. But it may be time for investors to take some profits and let the stock cool off.

What Investors Should Do After Nio Diluted Shares

By Chris Lau, InvestorPlace Contributor
Nio stock looks like a very cheap electric vehicle trade compared to Tesla but beware of near-term selling pressures ahead.

iBio’s Time Is Running Out in Vaccine Chase

By Faizan Farooque, InvestorPlace Contributor
Markets realize that the biotech firm is not close to delivering a vaccine, and IBIO stock is getting punished as a result.

Just One Number Will Convince You Not to Buy Zoom Stock

By David Moadel, InvestorPlace Contributor
It's okay to like the company, but if traditional valuation metrics mean anything anymore, then you might want to avoid ZM stock for now.

Frothy Valuation and Red Flags Mean Avoid Plug Power Stock at Today’s Prices

By Thomas Niel, InvestorPlace Contributor
In short, "priced for perfection," with factors at play that could sink shares back to prior levels, today's share price ($13 per share) is not a great entry point for PLUG stock.

There’s No Real Value Left in Whiting Petroleum Stock

By David Moadel, InvestorPlace Contributor
Sadly, a once mighty oil company is now going bankrupt. Knowing this, there's no need to gamble on fast-falling WLL stock.

There Are Still 1.6 Million Reasons You’re Wrong About Luckin Stock

By Chris Markoch, InvestorPlace Contributor
Despite its ongoing legal issues, Luckin stock still gets interest from speculative investors. But a flawed business model begs the question why?

Virgin Galactic Is Appealing to the Wrong Generation

By Josh Enomoto, InvestorPlace Contributor
SPCE stock may sound appealing at first glance but the finer details suggest that it’s less relevant to current investors than you might think.

iBio Is an Afterthought in the Covid-19 Vaccine Race

By Muslim Farooque, InvestorPlace Contributor
IBIO stock is a speculative play due to the slow development of its pipeline and its lack of much support from external parties.

With Buffett Selling Occidental Stock, Other Investors Probably Will Follow

By Ian Bezek, InvestorPlace Contributor
OXY stock has been through a lot this year. But until the price of oil picks up, there's still more pain ahead.

Under Armour Is Waking Up Far Too Late

By InvestorPlace Research Staff
When its rivals were taking a difficult stance for justice, Under Armour was busy being toxic. Now, that decision will come to haunt UA stock.

Taoping Isn’t the Chinese Stock to Embrace

By Todd Shriber, InvestorPlace Contributor
Taoping stock is a mess and things could get worse because the company isn't really capturing much of China's growing cloud market.

Marathon Patent Stock Is Not the Cryptocurrency Play You Might Think It Is

By Ian Bezek, InvestorPlace Contributor
Traders have bid up MARA stock as cryptos soar again. However, Marathon's crypto-mining business is nowhere near profitability yet.
Load More Articles